Skip to main content
Bernard Harris, MD, Preventive Medicine, Newtown Square, PA

Bernard Amiel Harris MD MPH

Public Health & General Preventive Medicine, Addiction Medicine


Medical Director, consultant in addiction medicine and public health

Join to view full profile
  • 18 Campus BlvdSte 100-1661Newtown Square, PA 19073

  • Phone+1 484-680-7575

  • Fax+1 484-328-6532

Dr. Harris is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Bernard Harris is a specialist in Preventive Medicine with subspecialties in Public Health & General Preventive Medicine and Addiction Medicine, based in Newtown Square, PA.

Education & Training

  • Zuckerberg San Francisco General Hospital and Trauma Center
    Zuckerberg San Francisco General Hospital and Trauma CenterInternship, Transitional Year, 1980 - 1981
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 1980

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2022 - 2027
  • PA State Medical License
    PA State Medical License 1981 - 2026
  • DE State Medical License
    DE State Medical License 2013 - 2025
  • NJ State Medical License
    NJ State Medical License 2013 - 2025
  • Public Health & General Preventive Medicine
    American Board of Preventive Medicine Public Health & General Preventive Medicine
  • Addiction Medicine
    American Board of Preventive Medicine Addiction Medicine
  • Fellow
    American Society of Addiction MedicineFellow

Awards, Honors, & Recognition

  • Pinnacle Award for Achievement in Business and Professional Excellence Gillette corp and Harbon Publishing, 1991

Clinical Trials

Publications & Presentations

Books/Book Chapters

Research History

  • Site Principle InvestigatorThe Ziagen Optimal Regimen and Resistance Observational (ZORRO) Trial. A Phase IV, open-label, community-based study conducted over 16 weeks at U.S. clinical practice sites to assess real-world safety/ tolerability and efficacy of abacavir- containing combination regimens.2000 - 2001

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: